| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan 48201 [Y. Q. C., S. C. C., J. M. A.], and Michigan Cancer Foundation, Detroit, Michigan 48202 [F. R. M.]
The p21WAF1 gene encodes a cyclin-dependent kinase inhibitor and mediates tumor suppressor gene p53-induced cell cycle arrest. To directly test whether p21WAF1 can act as a tumor suppressor, we have expressed the p21WAF1 cDNA in several human tumor cell lines using a tetracycline-inducible system. Overexpression of p21WAF1 suppresses proliferation and soft agar growth of tumor cells in vitro, as well as tumorigenicity in vivo. Our data provide direct evidence for the tumor-suppressive activity of p21WAF1.
1 Supported in part by American Cancer Society Grant IN-162 and a fund from the Pathology Department, Wayne State University.
2 To whom requests for reprints should be addressed, at Department of Pathology, Wayne State University, 540 East Canfield Avenue, Detroit, MI 48201. Phone: (313) 577-5634; Fax: (313) 577-0057; E-mail: yqchen@med.wayne.edu.
Received 6/27/95. Accepted 8/31/95.
This article has been cited by other articles:
![]() |
Y. Gong, J. Yue, X. Wu, X. Wang, J. Wen, L. Lu, X. Peng, B. Qiang, and J. Yuan NSPc1 is a cell growth regulator that acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE element Nucleic Acids Res., December 4, 2006; 34(21): 6158 - 6169. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, N. Sergina, T. C. Ko, J. Gong, and M. G. Brattain Autocrine and Exogenous Transforming Growth Factor {beta} Control Cell Cycle Inhibition through Pathways with Different Sensitivity J. Biol. Chem., September 17, 2004; 279(38): 40237 - 40244. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Bearss, R. J. Lee, D. A. Troyer, R. G. Pestell, and J. J. Windle Differential Effects of p21WAF1/CIP1 Deficiency on MMTV-ras and MMTV-myc Mammary Tumor Properties Cancer Res., April 1, 2002; 62(7): 2077 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Roman-Gomez, J. A. Castillejo, A. Jimenez, M. G. Gonzalez, F. Moreno, M. d. C. Rodriguez, M. Barrios, J. Maldonado, and A. Torres 5' CpG island hypermethylation is associated with transcriptional silencing of the p21CIP1/WAF1/SDI1 gene and confers poor prognosis in acute lymphoblastic leukemia Blood, April 1, 2002; 99(7): 2291 - 2296. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Waghray, D. Keppler, B. F. Sloane, L. Schuger, and Y. Q. Chen Analysis of a Truncated Form of Cathepsin H in Human Prostate Tumor Cells J. Biol. Chem., March 22, 2002; 277(13): 11533 - 11538. [Abstract] [Full Text] [PDF] |
||||
![]() |
U-J Gohring, A Bersch, M Becker, W Neuhaus, and T Schondorf p21waf correlates with DNA replication but not with prognosis in invasive breast cancer J. Clin. Pathol., November 1, 2001; 54(11): 866 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-P. Tsao, S.-J. Huang, J.-L. Chang, J.-T. Hsieh, R.-C. Pong, and S.-L. Chen Adenovirus-Mediated p21(WAF1/SDII/CIP1) Gene Transfer Induces Apoptosis of Human Cervical Cancer Cell Lines J. Virol., June 1, 1999; 73(6): 4983 - 4990. [Abstract] [Full Text] |
||||
![]() |
P. A. Hershberger, R. A. Modzelewski, Z. R. Shurin, R. M. Rueger, D. L. Trump, and C. S. Johnson 1,25-Dihydroxycholecalciferol (1,25-D3) Inhibits the Growth of Squamous Cell Carcinoma and Down-Modulates p21Waf1/Cip1 in Vitro and in Vivo Cancer Res., June 1, 1999; 59(11): 2644 - 2649. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Jones, X.-S. Cui, D. Medina, and L. A. Donehower Heterozygosity of p21WAF1/CIP1 Enhances Tumor Cell Proliferation and Cyclin D1-associated Kinase Activity in a Murine Mammary Cancer Model Cell Growth Differ., April 1, 1999; 10(4): 213 - 222. [Abstract] [Full Text] |
||||
![]() |
C. Mantel, S. E. Braun, S. Reid, O. Henegariu, L. Liu, G. Hangoc, and H. E. Broxmeyer p21cip-1/waf-1 Deficiency Causes Deformed Nuclear Architecture, Centriole Overduplication, Polyploidy, and Relaxed Microtubule Damage Checkpoints in Human Hematopoietic Cells Blood, February 15, 1999; 93(4): 1390 - 1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Mobley, T.-J. Liu, J. M. Hudson, and G. L. Clayman In Vitro Growth Suppression by Adenoviral Transduction of p21 and p16 in Squamous Cell Carcinoma of the Head and Neck: A Research Model for Combination Gene Therapy Arch Otolaryngol Head Neck Surg, January 1, 1998; 124(1): 88 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pinyol, L. Hernandez, M. Cazorla, M. Balbin, P. Jares, P. L. Fernandez, E. Montserrat, A. Cardesa, C. Lopez-Otin, and E. Campo Deletions and Loss of Expression of P16INK4a and P21Waf1 Genes Are Associated With Aggressive Variants of Mantle Cell Lymphomas Blood, January 1, 1997; 89(1): 272 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qiu, H. J. Forman, A. H. Schonthal, and E. Cadenas Induction of p21 Mediated by Reactive Oxygen Species Formed during the Metabolism of Aziridinylbenzoquinones by HCT116 Cells J. Biol. Chem., December 13, 1996; 271(50): 31915 - 31921. [Abstract] [Full Text] [PDF] |
||||
![]() |
X Chen, L J Ko, L Jayaraman, and C Prives p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes & Dev., October 1, 1996; 10(19): 2438 - 2451. [Abstract] [PDF] |
||||
![]() |
J. Zhu, S. Zhang, J. Jiang, and X. Chen Definition of the p53 Functional Domains Necessary for Inducing Apoptosis J. Biol. Chem., December 15, 2000; 275(51): 39927 - 39934. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |